Eli Lilly and Co

詳細情報 Eli Lilly and Co 企業名

Eli Lilly and Company is a medicine company, which discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity, and Zepbound. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing efforts, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer. It is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD). It also owns a lead therapeutic molecule, FXR314.

企業情報

企業コードLLY

会社名Eli Lilly and Co

上場日Jul 09, 1970

設立日1901

最高経営責任者「CEO」Mr. David A. (Dave) Ricks

従業員数47000

証券種類Ordinary Share

決算期末Jul 09

本社所在地Lilly Corporate Ctr

都市INDIANAPOLIS

証券取引所NYSE Consolidated

国United States of America

郵便番号46285

電話番号13172762000

ウェブサイトhttps://www.lilly.com/

企業コードLLY

上場日Jul 09, 1970

設立日1901

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Anne E. White

Executive Vice President, President - Lilly Neuroscience

74.21K

+13.18%

Mr. J. Erik Fyrwald

Independent Director

72.73K

+0.02%

Mr. Patrik Jonsson

Executive Vice President, President of Lilly Cardiometabolic Health and President, Lilly USA

54.13K

+20.12%

Mr. Edgardo Hernandez

Executive Vice President, President - Manufacturing Operations

39.75K

+4.13%

Mr. Ilya Yuffa

Executive Vice President, President of Lilly International

27.51K

-4.35%

Ms. Anat Hakim

Executive Vice President, General Counsel, Secretary

25.66K

-41.06%

Dr. Katherine Baicker, Ph.D.

Independent Director

23.16K

+0.62%

Mr. Diogo Rau

Executive Vice President, Chief Information and Digital Officer

19.72K

+77.63%

Mr. Lucas E. Montarce

Chief Financial Officer, Executive Vice President

13.97K

+26.18%

Mr. Eric Dozier

Executive Vice President - Human Resources and Diversity

9.84K

+15.72%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Anne E. White

Executive Vice President, President - Lilly Neuroscience

74.21K

+13.18%

Mr. J. Erik Fyrwald

Independent Director

72.73K

+0.02%

Mr. Patrik Jonsson

Executive Vice President, President of Lilly Cardiometabolic Health and President, Lilly USA

54.13K

+20.12%

Mr. Edgardo Hernandez

Executive Vice President, President - Manufacturing Operations

39.75K

+4.13%

Mr. Ilya Yuffa

Executive Vice President, President of Lilly International

27.51K

-4.35%

Ms. Anat Hakim

Executive Vice President, General Counsel, Secretary

25.66K

-41.06%

収益内訳

通貨: USD更新時刻: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Diabetes-Mounjaro

11.54B

25.62%

Oncology-Verzenio

5.31B

11.78%

Diabetes-Trulicity

5.25B

11.66%

Diabetes-Zepbound

4.93B

10.94%

Diabetes-Jardiance

3.34B

7.42%

Other

14.68B

32.58%

地域別USD

会社名

収益

比率

U.S.

30.38B

67.44%

Europe

6.92B

15.36%

Other foreign countries

4.27B

9.48%

Japan

1.81B

4.03%

China

1.66B

3.69%

事業別

地域別

事業別USD

会社名

収益

比率

Diabetes-Mounjaro

11.54B

25.62%

Oncology-Verzenio

5.31B

11.78%

Diabetes-Trulicity

5.25B

11.66%

Diabetes-Zepbound

4.93B

10.94%

Diabetes-Jardiance

3.34B

7.42%

Other

14.68B

32.58%

株主

更新時刻: Fri, May 16

株主統計

種類

株主統計

比率

Lilly Endowment, Inc.

10.13%

The Vanguard Group, Inc.

8.32%

PNC Investments LLC

5.39%

BlackRock Institutional Trust Company, N.A.

4.38%

State Street Global Advisors (US)

3.63%

Other

68.15%

株主統計

比率

Lilly Endowment, Inc.

10.13%

The Vanguard Group, Inc.

8.32%

PNC Investments LLC

5.39%

BlackRock Institutional Trust Company, N.A.

4.38%

State Street Global Advisors (US)

3.63%

Other

68.15%

種類

株主統計

比率

Investment Advisor

37.88%

Investment Advisor/Hedge Fund

26.78%

Foundation

10.13%

Research Firm

1.95%

Bank and Trust

1.80%

Pension Fund

1.80%

Insurance Company

1.47%

Sovereign Wealth Fund

1.26%

Hedge Fund

0.90%

Other

16.03%

機関投資家保有株

更新時刻: Thu, Feb 20

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q1

5632

794.97M

83.87%

+3.67M

2024Q4

5528

795.43M

83.87%

+627.51K

2024Q3

5177

793.57M

83.49%

-5.03M

2024Q2

5068

795.80M

83.72%

-2.01M

2024Q1

4916

795.04M

83.62%

-6.22M

2023Q4

4670

799.46M

84.21%

-2.37M

2023Q3

4354

800.21M

84.30%

-1.19M

2023Q2

4197

799.48M

84.22%

-4.32M

2023Q1

4061

801.36M

84.15%

-9.39M

2022Q4

3985

805.64M

84.79%

-7.51M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Lilly Endowment, Inc.

96.02M

10.13%

-220.00K

-0.23%

Mar 03, 2025

The Vanguard Group, Inc.

73.90M

7.8%

+486.78K

+0.66%

Dec 31, 2024

PNC Investments LLC

51.08M

5.39%

-49.68K

-0.10%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

41.11M

4.34%

+29.75K

+0.07%

Dec 31, 2024

State Street Global Advisors (US)

34.31M

3.62%

+461.69K

+1.36%

Dec 31, 2024

Fidelity Management & Research Company LLC

29.35M

3.1%

-2.42M

-7.60%

Dec 31, 2024

Geode Capital Management, L.L.C.

17.38M

1.83%

+291.88K

+1.71%

Dec 31, 2024

Capital World Investors

19.55M

2.06%

-803.44K

-3.95%

Dec 31, 2024

T. Rowe Price Associates, Inc.

19.73M

2.08%

-77.25K

-0.39%

Dec 31, 2024

Capital Research Global Investors

10.76M

1.13%

+1.49M

+16.12%

Dec 31, 2024

詳細を見る

関連ETF

更新時刻: Fri, Jun 6

銘柄名

比率

Defiance Daily Target 2X Long LLY ETF

27.66%

iShares U.S. Pharmaceuticals ETF

20.95%

Amplify Weight Loss Drug & Treatment ETF

14.48%

Roundhill GLP-1 & Weight Loss ETF

13.5%

Harbor Health Care ETF

13.03%

JPMorgan Healthcare Leaders ETF

12.25%

Health Care Select Sector SPDR Fund

11.37%

iShares U.S. Healthcare ETF

11.05%

Proshares Ultra Health Care

10.98%

Goldman Sachs Future Health Care Equity ETF

10.62%

詳細を見る

Defiance Daily Target 2X Long LLY ETF

比率27.66%

iShares U.S. Pharmaceuticals ETF

比率20.95%

Amplify Weight Loss Drug & Treatment ETF

比率14.48%

Roundhill GLP-1 & Weight Loss ETF

比率13.5%

Harbor Health Care ETF

比率13.03%

JPMorgan Healthcare Leaders ETF

比率12.25%

Health Care Select Sector SPDR Fund

比率11.37%

iShares U.S. Healthcare ETF

比率11.05%

Proshares Ultra Health Care

比率10.98%

Goldman Sachs Future Health Care Equity ETF

比率10.62%

配当金

過去5年間の配当金総支払額は 18.06B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Dec 09, 2024

LLY.NB Interim Cash Dividend of gross USD 1.5 paid on Mar 10, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Mar 10, 2025

Feb 14, 2025

Oct 28, 2024

LLY.NB Final Cash Dividend of gross USD 1.3 paid on Dec 10, 2024 going ex on Nov 15, 2024

Nov 15, 2024

Dec 10, 2024

Nov 15, 2024

Jun 24, 2024

LLY.NB Interim Cash Dividend of gross USD 1.3 paid on Sep 10, 2024 going ex on Aug 15, 2024

Aug 15, 2024

Sep 10, 2024

Aug 15, 2024

May 06, 2024

LLY.NB Interim Cash Dividend of gross USD 1.3 paid on Jun 10, 2024 going ex on May 15, 2024

May 16, 2024

Jun 10, 2024

May 15, 2024

Dec 08, 2023

LLY.NB Interim Cash Dividend of gross USD 1.3 paid on Mar 08, 2024 going ex on Feb 14, 2024

Feb 15, 2024

Mar 08, 2024

Feb 14, 2024

Nov 01, 2023

LLY.NB Final Cash Dividend of gross USD 1.13 paid on Dec 08, 2023 going ex on Nov 14, 2023

Nov 15, 2023

Dec 08, 2023

Nov 14, 2023

Jun 26, 2023

LLY.NB Interim Cash Dividend of gross USD 1.13 paid on Sep 08, 2023 going ex on Aug 14, 2023

Aug 15, 2023

Sep 08, 2023

Aug 14, 2023

May 01, 2023

LLY.NB Interim Cash Dividend of gross USD 1.13 paid on Jun 09, 2023 going ex on May 12, 2023

May 15, 2023

Jun 09, 2023

May 12, 2023

Dec 12, 2022

LLY.NB Interim Cash Dividend of gross USD 1.13 paid on Mar 10, 2023 going ex on Feb 14, 2023

Feb 15, 2023

Mar 10, 2023

Feb 14, 2023

Oct 17, 2022

LLY.NB Final Cash Dividend of gross USD 0.98 paid on Dec 09, 2022 going ex on Nov 14, 2022

Nov 15, 2022

Dec 09, 2022

Nov 14, 2022

詳細を見る

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

793.030USD

Eli Lilly and Co

793.030

概要

企業名